Stay updated on Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision metadata was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This update represents a minor documentation revision and does not alter study details, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2026-06-27T00:02:01.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page introduces new user-help sections and explicitly states recruitment changes, and it also includes a formatting update to the Intervention/Treatment label along with a Revision: v3.6.0 tag.
    Difference
    0.4%
    Check dated 2026-06-12T16:44:01.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The study page now shows a revised version tag (v3.5.5), replacing the previous v3.5.4. This indicates a small publishing or backend update rather than a substantive change to the trial details.
    Difference
    0.0%
    Check dated 2026-06-05T13:13:40.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    New study record dates were added (2026-05-26, 2027-02-18, 2026-05-07, 2026-05) and older dates were removed (2025-06-26, 2026-02-26, 2025-06-18, 2025-06), reflecting administrative updates to the study timeline in the Study Record Dates section.
    Difference
    0.2%
    Check dated 2026-05-29T09:16:09.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a newer release version. This appears to be a metadata update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-05-15T05:37:58.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page’s displayed system revision updated from v3.5.2 to v3.5.3, indicating a minor platform/version change without changing the study details.
    Difference
    0.0%
    Check dated 2026-04-24T06:12:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.